03:55 AM EDT, 07/01/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) said late Monday it has priced an underwritten public offering of about 24.2 million shares at $8.25 each for expected gross proceeds of $200 million.
The offering is expected to close on Wednesday, the company said.
Dyne Therapeutics ( DYN ) has granted underwriters a 30-day option to purchase up to 3.6 million additional shares.